Raymond James Financial Inc. Takes $1.30 Million Position in Huron Consulting Group Inc. (NASDAQ:HURN)

Raymond James Financial Inc. purchased a new position in shares of Huron Consulting Group Inc. (NASDAQ:HURN - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 10,477 shares of the business services provider's stock, valued at approximately $1,301,000. Raymond James Financial Inc. owned 0.06% of Huron Consulting Group as of its most recent filing with the SEC.

Several other large investors also recently added to or reduced their stakes in HURN. Dakota Wealth Management raised its holdings in Huron Consulting Group by 4.0% during the 4th quarter. Dakota Wealth Management now owns 2,250 shares of the business services provider's stock valued at $280,000 after acquiring an additional 87 shares during the period. Andina Capital Management LLC raised its stake in shares of Huron Consulting Group by 3.4% during the 4th quarter. Andina Capital Management LLC now owns 3,296 shares of the business services provider's stock valued at $410,000 after purchasing an additional 107 shares during the period. Keybank National Association OH grew its holdings in Huron Consulting Group by 4.2% during the 4th quarter. Keybank National Association OH now owns 4,120 shares of the business services provider's stock valued at $512,000 after buying an additional 167 shares in the last quarter. Heck Capital Advisors LLC purchased a new stake in shares of Huron Consulting Group in the fourth quarter worth about $33,000. Finally, Diversified Trust Co grew its stake in Huron Consulting Group by 9.1% during the fourth quarter. Diversified Trust Co now owns 5,907 shares of the business services provider's stock valued at $734,000 after acquiring an additional 493 shares in the last quarter. Hedge funds and other institutional investors own 93.90% of the company's stock.

Remove Ads

Huron Consulting Group Price Performance

Shares of NASDAQ HURN traded down $1.08 during trading hours on Monday, reaching $136.68. 469,871 shares of the stock traded hands, compared to its average volume of 137,920. The company's 50-day simple moving average is $138.12 and its two-hundred day simple moving average is $125.36. The company has a market capitalization of $2.45 billion, a P/E ratio of 29.71 and a beta of 0.37. Huron Consulting Group Inc. has a 52-week low of $84.26 and a 52-week high of $153.85. The company has a quick ratio of 1.61, a current ratio of 1.61 and a debt-to-equity ratio of 0.82.

Huron Consulting Group (NASDAQ:HURN - Get Free Report) last announced its quarterly earnings data on Tuesday, February 25th. The business services provider reported $1.90 earnings per share for the quarter, topping analysts' consensus estimates of $1.52 by $0.38. Huron Consulting Group had a net margin of 5.80% and a return on equity of 21.51%. The firm had revenue of $399.31 million during the quarter, compared to analyst estimates of $380.62 million. Equities research analysts forecast that Huron Consulting Group Inc. will post 6.1 EPS for the current year.

Insider Buying and Selling at Huron Consulting Group

In related news, Director James H. Roth sold 2,000 shares of the company's stock in a transaction on Wednesday, January 8th. The shares were sold at an average price of $123.69, for a total transaction of $247,380.00. Following the completion of the sale, the director now directly owns 50,534 shares in the company, valued at $6,250,550.46. This represents a 3.81 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director John Mccartney sold 500 shares of the company's stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $151.13, for a total transaction of $75,565.00. Following the transaction, the director now directly owns 55,688 shares of the company's stock, valued at approximately $8,416,127.44. This trade represents a 0.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 80,781 shares of company stock worth $11,731,832 over the last three months. Company insiders own 2.02% of the company's stock.

Wall Street Analyst Weigh In

Several research firms have issued reports on HURN. Truist Financial increased their target price on shares of Huron Consulting Group from $165.00 to $180.00 and gave the stock a "buy" rating in a research note on Tuesday, March 4th. Benchmark restated a "buy" rating and issued a $165.00 target price on shares of Huron Consulting Group in a research note on Wednesday, March 26th. Wedbush boosted their price objective on Huron Consulting Group from $150.00 to $165.00 and gave the stock an "outperform" rating in a report on Wednesday, March 26th. William Blair reaffirmed an "outperform" rating on shares of Huron Consulting Group in a research note on Wednesday, March 26th. Finally, Barrington Research reiterated an "outperform" rating and set a $167.00 target price on shares of Huron Consulting Group in a research report on Thursday, March 27th. Six investment analysts have rated the stock with a buy rating, According to MarketBeat, Huron Consulting Group has a consensus rating of "Buy" and a consensus target price of $169.25.

Huron Consulting Group Company Profile

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children's and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.